Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

Fortress Biotech (FBIO) Preferred Shares Issued: 2013-2023

Historic Preferred Shares Issued for Fortress Biotech (FBIO) over the last 4 years, with Mar 2023 value amounting to $652,000.

  • Fortress Biotech's Preferred Shares Issued was N/A to $652,000 in Q1 2023 from the same period last year, while for Mar 2023 it was $17.6 million, marking a year-over-year change of. This contributed to the annual value of $17.0 million for FY2021, which is 56.57% down from last year.
  • As of Q1 2023, Fortress Biotech's Preferred Shares Issued stood at $652,000, which was down 84.37% from $4.2 million recorded in Q3 2021.
  • Fortress Biotech's 5-year Preferred Shares Issued high stood at $14.4 million for Q1 2020, and its period low was $263,000 during Q2 2021.
  • Over the past 2 years, Fortress Biotech's median Preferred Shares Issued value was $2.4 million (recorded in 2021), while the average stood at $4.4 million.
  • In the last 5 years, Fortress Biotech's Preferred Shares Issued soared by 628.26% in 2019 and then slumped by 97.71% in 2021.
  • Over the past 4 years, Fortress Biotech's Preferred Shares Issued (Quarterly) stood at $6.0 million in 2019, then reached $13.2 million in 2020, then slumped by 68.40% to $4.2 million in 2021, then reached $652,000 in 2023.
  • Its Preferred Shares Issued was $652,000 in Q1 2023, compared to $4.2 million in Q3 2021 and $263,000 in Q2 2021.